ClinicalTrials.gg
Active, not recruitingNCT07111663Updated Nov 13, 2026

An Observational Study of Individuals With Isolated Dystonia

An observational study in Isolated/Primary Dystonia That Affects More Than One Region of the Body, sponsored by Vima Therapeutics. Active, not recruiting at 29 sites in United States. Open to participants aged 12 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Vima Therapeutics · Observational

How we know

Updated Nov 13, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
12 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 118 studies in Dystonia with a site in United States — 27 open to participants now, 31 under way, none of them phase 3. Dystonia · United States.

Planned enrollment
13th of 56
200 · median 80
Started
2025
with 2 others
Observational
56 of 118
12 open now
Primary completion
2026-11
later than 2 of 30 live
Registered
113th of 118
by date

Among the 118 studies in Dystonia with a site in United States, this one is the 13th largest by planned enrollment of the 56 observational ones that give a count, is one of 3 that started in 2025, is one of 56 observational ones, reaches primary completion later than 2 of the 30 other live ones, and was the 113th registered.

Dystonia

213 studies on the registry are indexed under Dystonia; 54 are open to participants now.

Browse Dystonia studies →

Open to participants now

27 of the 118 studies in Dystonia with a site in United States are open now. Recruiting first, the newest first:

22 more — sign in →

All 27 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 41 Dystonia studies recruiting now, 19 (46%) set no upper age limit and 10 (24%) stop at 75 or younger; 18 take children under 18; 6 take healthy volunteers.

This study: 12 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 118 studies in Dystonia with a site in United States, or all of them as a file.
02

Study summary

This is an observational study in individuals with isolated (or primary) dystonia that involves more than one body region. The purpose of the study is to collect detailed information to help your physician and other researchers understand how dystonia impacts your and other patients' lives and how the disease changes over time. The study may also help researchers better understand the clinical scales that are commonly used to evaluate dystonia symptoms and how they affect various areas of life such as well-being, pain, relationships and social interactions, and progress over time. Because this is an observational study, you will not receive any interventional treatment in the study.

Read the detailed description

The primary goal of this observational study is to further characterize and quantify disease severity and impact (including change over time) in individuals with either segmental, multifocal, or generalized dystonia in a structured manner, utilizing and comparing various well-known scales. In addition, medication history and any intercurrent events related to the participant's health (such as, but not limited to, hospitalizations, new diagnoses, etc.) will be captured. This study will provide standardized data to support planned future interventional clinical studies in this patient population and will provide a greater understanding of the population under study and the performance of clinical ratings scales.

03

Conditions studied

  • Isolated/Primary Dystonia That Affects More Than One Region of the Body

Keywords

  • Dystonia, Isolated Dystonia, Primary Dystonia, Cervical Dystonia
04

Who can participate

Ages eligible
12 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Isolated (Primary) Dystonia

Eligibility criteria

Inclusion Criteria: Each participant must meet the following criteria at Visit 1 to be eligible to continue in the study:

  • The participant is willing to sign an form indicating that he/she understands the purpose of the study; understands and can perform, complete, and comply with all the assessments that are required during the study; and is willing to participate in the study.
  • The participant is a male or female between 12 and 65 years of age (inclusive).
  • The participant has a clinical diagnosis of isolated (or primary) dystonia for at least one year prior to Visit 1 and meets the study definition of segmental/multifocal or generalized dystonia at Visit 1.

Exclusion Criteria: Any participant who meets any of the following criteria at Visit 1 will be excluded from this study:

  • The participant has a diagnosis of focal dystonia at Visit 1.
  • The participant has a diagnosis of dopa-responsive dystonia, secondary dystonia, or psychogenic/functional dystonia.
  • The participant has any significant ongoing disease, disorder, laboratory abnormalities, alcohol or illicit drug abuse or dependence, environmental factor, or any ongoing or history of any medical or surgical condition that in the judgment of the investigator, in consultation with the medical monitor and/or sponsor's designee, might jeopardize the participant's safety, impact the scientific objectives of the clinical study, or interfere with participation in the clinical study.
  • The participant has a history of any psychiatric or cognitive impairment disorder that, in the opinion of the investigator, may interfere with study conduct.
  • The participant has had myotomy or denervation surgery in any affected muscles (e.g., peripheral denervation and/or spinal cord stimulation).
  • The participant has marked limitation on passive range of motion that suggests contractures or other structural abnormality (e.g., cervical contractures or cervical spine syndrome).
  • The participant has undergone deep brain stimulation (DBS) surgery (even if implant deactivated).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Isolated (or Primary) Dystonia Cohort

    This is a single-arm noninterventional, prospective observational study enrolling up to 200 male and female participants (ages 12 - 65 years, inclusive) that have been diagnosed with isolated dystonia for at least one year prior to the first study visit. Candidates with focal dystonia (i.e., only one body part affected) are not eligible for participation. However, the Investigator may query such patients to determine if symptoms have spread to other regions, which may allow them to be eligible for study entry.

06

What researchers measure

Primary outcomes

  1. Burke-Fahn-Marsden (BFM) Dystonia Rating Scale

    The BFM was developed to quantitatively assess primary dystonias (Burke 1985). It is composed of 2 subscales: a movement subscale, based on the clinician's evaluation of the patient in nine body areas, and a disability subscale, based on the participant's report of disability in activities of daily living.

    Time frame: From start of treatment through 4 months

Secondary outcomes

  1. Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS-2)

    The TWSTRS-2 scale is used to assess cervical dystonia. It includes 3 subscales that evaluate symptom severity, disability, and pain. The severity scale is clinician-rated and the disability scale is patient-rated based on 6 items related to work, activities of daily living, driving, reading, watching TV, and outside activities.

    Time frame: From start of treatment through 4 months

  2. Clinical Global Impression of Severity (CGI-S)

    The CGI-S score is used by the Investigator to determine, in a global sense, how severe the patients' blepharospasm is in the context of other blepharospasm patients. Increased scores indicate more severe symptoms.

    Time frame: From start of treatment through 4 months

07

Study locations

29 sites
  • Vima Site #004
    Scottsdale, Arizona 85258, United States
  • Vima Site #028
    Sun City, Arizona 85351, United States
  • Vima Site #010
    Aliso Viejo, California 92656, United States
  • Vima Site #030
    Los Angeles, California 97239, United States
  • Vima Site #022
    Palo Alto, California 94301, United States
  • Vima Site #019
    Englewood, Colorado 80113, United States
  • Vima Site #003
    Boca Raton, Florida 33486, United States
  • Vima Site #009
    Gainesville, Florida 32611, United States
  • Vima Site #008
    Miami, Florida 33176, United States
  • Vima Site #031
    Orlando, Florida 32825, United States
  • Vima Site #005
    Atlanta, Georgia 30322, United States
  • Vima Site #027
    Chicago, Illinois 60611, United States
  • Vima Site #007
    Olney, Maryland 20832, United States
  • Vima Site #002
    Farmington Hills, Michigan 48334, United States
  • Vima Site #014
    Albuquerque, New Mexico 87106, United States
  • Vima Site #017
    Commack, New York 11725, United States
  • Vima Site #018
    New York, New York 10029, United States
  • Vima Site #024
    New York, New York 10065, United States
  • Vima Site #029
    Portland, Oregon 97239, United States
  • Vima Site #020
    Philadelphia, Pennsylvania 19107, United States
  • Vima Site #021
    Charleston, South Carolina 29407, United States
  • Vima Site #016
    Memphis, Tennessee 38157, United States
  • Vima Site #006
    Nashville, Tennessee 37232, United States
  • Vima Site #025
    Dallas, Texas 75390, United States
  • Vima Site #026
    Georgetown, Texas 78628, United States
  • Vima Site #012
    Houston, Texas 77030, United States
  • Vima Site #011
    Richmond, Virginia 23298, United States
  • Vima Site #023
    Kirkland, Washington 98034, United States
  • Vima Site #015
    Spokane, Washington 99202, United States
08

References and documents

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for Nov 2026, 17 months after the start.

Of 27 observational studies under Dystonia, half reached primary completion within 72 months of starting (the median), counting those still running; a quarter within 58 and three quarters within 188. This study's planned 17 months is below that.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 13, 2026: primary completion Oct 2026 → Nov 2026 and completion Oct 2026 → Nov 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 1, 2025
First posted
Aug 8, 2025
StartActual
Jun 17, 2025
Primary completionEst.
Nov 2026was Oct 2026
CompletionEst.
Nov 2026was Oct 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Oct 2026→Nov 2026
Nov 13, 2026
Study completion
Oct 2026→Nov 2026
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    Primary completion Oct 2026→Nov 2026
    Study completion Oct 2026→Nov 2026

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07111663
Lead sponsor
Vima Therapeutics
Responsible party
Sponsor
First posted
Aug 8, 2025
Start date
Jun 17, 2025
Primary completion
Nov 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Nov 13, 2026

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion